Delafloxacin: design, development and potential place in therapy

Delafloxacin: design, development and potential place in therapy

Francisco Javier Candel, Marina Peñuelas Department of Clinical Microbiology and Infectious Diseases, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Universidad Complutense, Madrid, Spain Abstract: Delafloxacin (DLX) is a new...

Full description

Bibliographic Details
Main Authors:	Candel FJ, Peñuelas M
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-03-01
Series:	Drug Design, Development and Therapy
Subjects:	Delafloxacin fluoroquinolones methicillin-resistant Staphylococcus aureus therapy
Online Access:	https://www.dovepress.com/delafloxacin-design-development-and-potential-place-in-therapy-peer-reviewed-article-DDDT

Similar Items

Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
by: Righi E, et al.
Published: (2018-04-01)

Evaluation of Delafloxacin against a Burkholderia pseudomallei Efflux Mutant Panel
by: Sandra P. McCurdy, et al.
Published: (2022-10-01)

Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
by: Ioanna Vlachaki, et al.
Published: (2021-10-01)

Delafloxacin-Capped Gold Nanoparticles (DFX-AuNPs): An Effective Antibacterial Nano-Formulation of Fluoroquinolone Antibiotic
by: Amr Selim Abu Lila, et al.
Published: (2022-08-01)

Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis
by: Beverley Cherie Millar, et al.
Published: (2021-01-01)

In Vitro Activity of Delafloxacin and Finafloxacin against Mycoplasma hominis and Ureaplasma Species
by: Yingying Kong, et al.
Published: (2022-06-01)

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?
by: Neeta D Gade, et al.
Published: (2013-07-01)

Fluoroquinolones and Risk for Methicillin-Resistant Staphylococcus aureus, Canada
by: Louiselle LeBlanc, et al.
Published: (2006-09-01)

Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial
by: Sandra McCurdy, et al.
Published: (2020-08-01)

Length of exposure to the hospital environment is more important than antibiotic exposure in healthcare associated infections by methicillin-resistant Staphylococcus aureus: a comparative study
by: Ioannis G Baraboutis, et al.

Outbreak of methicillin-resistant Staphylococcus aureus sequence type 1, spa type t1784, in an equine hospital in Japan
by: Eri Uchida-Fujii, et al.
Published: (2022-09-01)

Investigation of Delafloxacin Resistance in Multidrug-Resistant <i>Escherichia coli</i> Strains and the Detection of <i>E. coli</i> ST43 International High-Risk Clone
by: Dániel Gulyás, et al.
Published: (2023-06-01)

Levonadifloxacin: A Novel Approved Drug Exhibiting Potent In vitro Activity against Gram Positive Bacterial Isolates from Patients Admitted in Intensive Care Units
by: Tasneem Siddiqui, et al.
Published: (2021-07-01)

Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)
by: Dee Shortridge, et al.
Published: (2020-12-01)

Development of Lipomer Nanoparticles for the Enhancement of <i>Drug</i> Release, Anti-Microbial Activity and Bioavailability of Delafloxacin
by: Md. Khalid Anwer, et al.
Published: (2020-03-01)

Nasal colonization in children with community acquired methicillin-resistant Staphylococcus aureus
by: Fazlollah Davoodabadi, et al.
Published: (2016-01-01)

Antimicrobial Susceptibility Pattern of Methicillin-Resistant Staphylococcus aureus in a Tertiary care Hospital
by: Aqsa Aslam, et al.
Published: (2022-11-01)

Spectroscopic Studies of Delafloxacin Meglumine
by: Xin-yi ZHAO, et al.
Published: (2021-06-01)

A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections
by: William O’Riordan, et al.
Published: (2015-01-01)

Evolving rapid methicillin-resistant Staphylococcus aureus detection: Cover all the bases
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2017-01-01)

Mechanisms of anti-microbial action of tunicate (Polycarpa papillata) extract against methicillin resistant Staphylococcus aureus and methicillin susceptible Staphylococcus aureu
by: Mohd Yaakob, Haslinda Ayu
Published: (2013)

Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant staphylococcus aureus (MRSA)
by: Mohtar, Mastura, et al.
Published: (2009)

A SUPERBUG (METHICILLIN RESISTANT STAPHYLOCOCCUS AUERUS) IN HUMAN
by: Sumaira Kanwal, et al.
Published: (2014-12-01)

Detection of icaABCD Genes in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus from Patients in Iran
by: Safiyeh Abbasi, et al.
Published: (2015-07-01)

Correlación entre la detección de superantígenos y resistencia a oxacilina en aislamientos hospitalarios de Staphylococcus aureus
by: José-Ignacio Moncayo-Ortiz, et al.

The efficacy and adverse events of delafloxacin in the treatment of acute bacterial infections: A systematic review and meta-analysis of randomized controlled trials
by: Rong He, et al.
Published: (2022-09-01)

Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
by: Béla Kocsis, et al.
Published: (2021-12-01)

Updated Review on Clinically-Relevant Properties of Delafloxacin
by: Adrien Turban, et al.
Published: (2023-07-01)

Study of the role of mobile phones in the transmission of Hospital acquired infections
by: Kalpana M Angadi, et al.
Published: (2014-01-01)

Methicillin-Resistant Staphylococcus aureus Using Broth Micro Dilution Method in Iran: A Meta-Analysis (2007-2016)
by: Ghobad Moradi, et al.
Published: (2018-10-01)

Molecular typing revealed the emergence of pvl-positive sequence type 22 methicillin-susceptible Staphylococcus aureus in Urumqi, Northwestern China
by: Yuan W, et al.
Published: (2019-06-01)

Molecular study on methicillin-resistant Staphylococcus aureus strains isolated from dogs and associated personnel in Jordan
by: Yaser Hamadeh Tarazi, et al.
Published: (2015-11-01)

spa diversity of methicillin-resistant and -susceptible Staphylococcus aureus in clinical strains from Malaysia: a high prevalence of invasive European spa-type t032
by: Sherry Usun Jones, et al.
Published: (2021-04-01)

SUSCEPTIBILITY PATTERN OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BACTERIA IN DR. SOETOMO GENERAL ACADEMIC HOSPITAL SURABAYA
by: Sacharissa Zerlina Tsarwah Thirafi, et al.
Published: (2022-10-01)

Prevalence and determinants of methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus carrier among staff of a tertiary eye hospital in Saudi Arabia
by: Ruhi A Khan, et al.
Published: (2021-01-01)

Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?
by: Aura Rusu, et al.
Published: (2023-03-01)

Investigation of the Effect of Animal Contact on Nasal Staphylococcus aureus Carriage
by: M. Hamidullah UYANIK, et al.
Published: (2009-09-01)

Screening of methicillin-resistant Staphylococcus aureus in healthcare workers and students and its susceptibility to mupirocin in a tertiary care teaching hospital in South India
by: Jutang Babat Ain Tiewsoh, et al.
Published: (2017-10-01)

Nasal carriage screening of community-associated methicillin resistant Staphylococcus aureus in healthy children of a developing country
by: Sina Mobasherizadeh, et al.
Published: (2016-01-01)

Frequency of Isolation of Methicillin-resistant Staphylococcus Aureus (MRSA) from Pus Samples and its Antibiotic Susceptibility
by: Fatima Rubab, et al.
Published: (2023-04-01)